These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8911337)

  • 21. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
    Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
    Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.
    Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Shimada M; Takahashi M; Nakamura T; Sato K; Terakawa N
    Eur J Cancer; 1998 Oct; 34(11):1802-6. PubMed ID: 9893672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 tumor suppressor gene therapy for cancer.
    Roth JA; Swisher SG; Meyn RE
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
    Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R
    Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2 gene transfer prevents NKG2D suppression and enhances antitumor efficacy in combination with cisplatin for head and neck squamous cell cancer.
    Li D; Ronson B; Guo M; Liu S; Bishop JS; Van Echo DA; O'Malley BW
    Cancer Res; 2002 Jul; 62(14):4023-8. PubMed ID: 12124336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin.
    Wang S; Li W; Xue Z; Lu Y; Narsinh K; Fan W; Li X; Bu Q; Wang F; Liang J; Wu K; Cao F
    Mol Carcinog; 2013 Nov; 52(11):900-7. PubMed ID: 22674879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53.
    Pataer A; Fanale MA; Roth JA; Swisher SG; Hunt KK
    Cancer Gene Ther; 2006 Aug; 13(8):806-14. PubMed ID: 16628227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
    You L; Yang CT; Jablons DM
    Cancer Res; 2000 Feb; 60(4):1009-13. PubMed ID: 10706117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA.
    Jiang T; Zhou C; Gu J; Liu Y; Zhao L; Li W; Wang G; Li Y; Cai L
    Cancer Lett; 2013 Aug; 337(1):133-42. PubMed ID: 23726840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
    Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
    Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
    Riva CM
    Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells.
    Neukirchen J; Meier A; Rohrbeck A; Garcia-Pardillos G; Steidl U; Fenk R; Haas R; Kronenwett R; Rohr UP
    Cancer Gene Ther; 2007 Apr; 14(4):431-9. PubMed ID: 17235352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer].
    Fujiwara T; Inoue F; Tanaka N
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):194-200. PubMed ID: 9474928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
    Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
    Harada N; Maniwa Y; Yoshimura M; Nagata M; Hamada H; Yokono K; Okita Y
    Oncol Rep; 2005 Nov; 14(5):1155-63. PubMed ID: 16211279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.
    Inoue A; Narumi K; Matsubara N; Sugawara S; Saijo Y; Satoh K; Nukiwa T
    Cancer Lett; 2000 Aug; 157(1):105-12. PubMed ID: 10893449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.